The cold relief roll on market size is projected to surpass a valuation of US$ 1,156.5 million by 2033. As per the analysis, the cold relief roll on market is likely to record a CAGR of 8.3% through 2033. As of 2023, the current market valuation stands at a substantial US$ 520.9 million.
| Attributes | Details |
|---|---|
| Cold Relief Roll On Market Size 2022 | US$ 484.3 million |
| Cold Relief Roll On Market Size 2023 | US$ 520.9 million |
| Cold Relief Roll On Market Size 2033 | US$ 1,156.5 million |
| Value CAGR (2023 to 2033) | 8.3% |
| Market Share of Top 5 Countries | 52.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Healthcare expenditure is increasing significantly, especially in emerging countries, which is creating many opportunities for the cold relief roll on market growth. For instance, according to the Centers for Medicare & Medicaid Services (CMS), spending on health care in the United States increased by 9.7 per cent in 2020 to US$ 4.1 trillion, or US$ 12,530 per person. The amount spent on health represented 19.7 percent of the country's GDP. In Germany, current health spending stands at around 11.7% of the GDP. In France, it is 11.0%, 10.8% for Canada, 10.7% for Japan, 9.1% for South Africa, and 5.3% for China.
Spending on healthcare is rising as well, which is a clear sign that healthcare systems are getting better across the world. The market for cold relief roll on is likely to have more potential to grow overall as a result of such initiatives and funding. Consequently, between 2023 and 2033, the industry has a great chance for growth.
Globally shifting lifestyles, improved patient adherence, an expanding geriatric population, and rising pollution levels are anticipated to boost market size throughout the projection period. Throughout the assessment year, rising demand for self-administration is anticipated to present lucrative growth prospects for the global cold relief roll on market. Additionally, a variety of advantages provided by cold relief roll-on, including efficient pain relief, increased patient convenience, and straightforward accessibility, are significant market drivers. Enhancing the product offerings in the market by the top players over the forecast period from 2023 to 2033 is likely to contribute to the market's continued growth.
| Attributes | Details |
|---|---|
| Cold Relief Roll On Market Size (2018) | US$ 370.3 million |
| Cold Relief Roll On Market Size (2022) | US$ 484.3 million |
| Cold Relief Roll On Market CAGR (2018 to 2022) | 6.7% |
Sales of cold relief roll on market expanded at a CAGR of 6.7% from 2018 to 2022 owing to the increased adoption of different cold relief roll on. The increase in nasal allergies and nasal congestion is responsible for the market's growth. According to government statistics, about half of individuals in the United States have severe nasal infection symptoms at least seven days a year.
The global cold relief roll on market is anticipated to benefit from the growing acceptance of self-administration methods. The market growth is anticipated to accelerate during the forecast period due to the increased patient preference for roll on medication delivery due to its simplicity of administration and superior efficacy characteristics.
The forward-thinking development of cold relief medications, spearheaded by medical professionals, presents the market with ample opportunities for expansion and involves the creation of medications with low adverse effects. For investors in the industry, this offers a profitable opportunity with a potential CAGR of 8.3% globally between 2023 and 2033.
Principal Consultant
Optimizing digital sales channels is critical, given the ongoing prevalence of online shopping. It's vital to improve eCommerce platforms, implement successful digital marketing tactics, and guarantee a flawless online shopping experience. This increases the brand's exposure and competitiveness in the digital marketplace, in addition to leveraging the growing eCommerce ecosystem.
In the field of cold relief, people are living in a customized medicine age. Customizing products based on consumer preferences, medical conditions, and demographics offers a unique way to stand out in the cold relief roll on market. By offering tailored solutions that address specific customer requirements, businesses employing this strategy can develop a devoted clientele that supports brand affinity and repeat business.
Factors Restraining the Demand for Cold Relief Roll On
To treat the symptoms of allergic rhinitis, many cold relief medications are easily accessible and can be purchased over the counter. However, continued use of these drugs has the potential to worsen symptoms, including breathing problems, and may damage the nose and other body parts. Since cold relief roll-ons and other related nasal sprays are so accessible to patients, many people mistakenly believe they are safe to use and are unaware of any potential side effects or addiction. These side effects dissuade people from opting for cold relief medications, negatively affecting the overall market growth.
| Countries | Value CAGR (2023 to 2033) |
|---|---|
| United States | 7.6% |
| China | 6.8% |
| Germany | 6.4% |
| India | 7.8% |
| Japan | 8.0% |
The demand of cold relief roll on in the United States is projected to thrive at a 7.6% CAGR through 2033. More than millions of cases of the common cold are reported each year in the United States, according to a study by the Centers for Disease Control and Prevention (CDC). Children get many more colds than adults, typically experiencing two to three per year. Colds can strike at any time of the year; however, they are more common in the winter or spring. Thus, a large population suffering from chronic colds and coughs and growing pain management awareness are two top contributing factors to the United States' large market share.
The cold relief roll on market size in China is projected to increase at a CAGR of 6.8% through 2033. Since 1970, the average Chinese person's life expectancy has increased by 17 years. It is predicted that 28% of people in the country are going to be 60 years of age or older by the year 2040. China's health ministry reported in November 2023 that the recent surge in respiratory illnesses, which has captured the attention of the World Health Organization, is attributed to familiar pathogens such as the flu and other known viruses Additionally, bacteria such as mycoplasma pneumonia, commonly associated with respiratory tract infections, contribute to these recent cases. Children get many more colds than adults, typically experiencing two to three per year. Colds can strike at any time of the year; however, they are more common in the winter or spring.
The sales of cold relief roll on in Germany are set to exhibit a CAGR of nearly 6.4% through 2033. The factor influencing the growth of the market in Germany is anticipated to be the government improving healthcare facilities. Government spending on health in the European Union accounted for 8% of GDP in 2020. Another important element predicted to boost the country's market throughout the projection period is the introduction of new goods in the area. For instance, Glenmark Pharmaceuticals declared in 2021 that its fixed-dose combination nasal spray, Ryaltris, had acquired commercial approval in 13 nations throughout the European Union.
The cold relief roll on market in India are predicted to increase at a CAGR of 7.8% through 2033. This growth is associated with the significant investments of large and small pharmaceutical companies in research facilities as well as research and development operations in recent years. Also, healthcare expenditures and medical infrastructure development are rapidly improving. These factors are expected to drive market growth in India during the forecast years.
The adoption of cold relief roll on in Japan is projected to thrive at an 8.0% CAGR through 2033. Japan's urbanization has resulted in people leading busier lives. Convenient and efficient cold relief products are in higher demand as urban inhabitants prioritize their health and fitness despite hectic schedules. Businesses can satisfy this need by marketing their goods as portable, on-the-go solutions for people living in contemporary cities.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Segment | Nasal Congestion (Application) |
|---|---|
| Value Share (2023) | 36.5% |
Nasal congestion segment occupied a market share of around 36.5% in 2023. Globally, there has been a significant rise in the incidence of infectious diseases and allergic conditions. According to global demand, the increase in allergy cases is leading to a significant uptick in the production of cold relief roll-on medications. Thus, the increased prevalence of allergic illnesses is anticipated to boost overall revenue sales of cold remedies as the projection period ends by 2033.
| Segment | Retail Pharmacies (Distribution Channel) |
|---|---|
| Value Share (2023) | 31.1% |
Retail pharmacies provide customers with unmatched accessibility and convenience. Customers don't have to wait in long lines or make extended trips to obtain cold relief items because they are widely available in their local areas. This convenience is particularly important when dealing with urgent medical demands, including cold symptoms. Digital integration has been embraced by several retail pharmacies in response to changing consumer expectations. Customers can explore items, get information, and order in-store pickup or home delivery online. This digital convenience aligns with contemporary buying patterns and enhances the overall consumer experience.
Key players in the cold relief roll-on market are focusing their efforts on expanding their geographical presence as well as collaborations as key strategies. These strategies help market players enhance their product portfolio and market penetration, thereby increasing their overall revenue share in the global market.
Recent Developments
| Attribute | Details |
|---|---|
| Historical Data Available for | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Market Analysis | US$ million for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, France, Spain, Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC countries, Turkey, South Africa and North Africa. |
| Key Market Segments Covered | Application, Distribution Channel and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The cold relief roll on market size is valued at US$ 520.9 million in 2023.
The cold relief roll on market is expected to reach US$ 1,156.5 million by the end of 2033, registering an 8.3% CAGR.
The cold relief roll on market in India is likely to thrive at a CAGR of 7.8% through 2033.
Germany’s market for cold relief roll on is expected to exhibit a 6.4% CAGR through 2033.
The United States, China, Germany, India and Japan are expected to drive demand for cold relief roll on.
From 2018 to 2022, the market for cold relief roll on expanded at the rate of 6.7%.
Glaxosmithkline, Abbott Laboratories, Procter and Gamble, Viatris Inc., Johnson & Johnson, Cipla Ltd., INNOVUS PHARMACEUTICALS, INC, Novartis AG (Sandoz International GmbH), Mylan N.V., Sumitomo Dainippon Pharma (Sunovion Pharmaceuticals Inc.) , Nipro Corporation (NIPRO JMI Pharma Ltd.), Glenmark pharmaceutical ltd. , Berry Global, Inc., Astra Zeneca Plc. and Lupin pharmaceuticals, Inc. are the key exporters of cold relief roll on market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Market Round Offs 1.5. FMI Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Brand Mapping Analysis 3.1. Price v/s Product 3.2. Value for Money 3.3. Top-of-Mind 3.4. Brand Portfolio-by Key Players 3.5. Brand Loyalty Mapping 3.6. Usage Pattern Overview 3.7. Branded vs Unbranded-Market Mix 4. Distribution Channel Wise Key Brand Positioning 4.1. Global Top Retailers and their Brand Offerings 4.1.1. Retail Pharmacies 4.1.2. Hospital Pharmacies 4.1.3. E-Commerce 4.1.4. Hypermarket/Supermarket 4.2. Retail Pricing Strategies 5. Consumer Buying Behavior Analysis 5.1. Functionality and Product Demand 5.1.1. Cold/Cough 5.1.2. Nasal Allergies 5.1.3. Nasal Congestion 5.1.4. Others 5.2. What factors do you consider when deciding to purchase Cold Relief Roll On? 5.3. How important are product certifications when choosing Cold Relief Roll On? 5.4. How important is the brand reputation and recognition when selecting Cold Relief Roll On? 5.5. What marketing channels do you prefer for learning about new Cold Relief Roll On? 5.6. How often do you purchase new Cold Relief Roll On? 5.6.1. Once or More Every Month 5.6.2. Once Every 2 months 5.6.3. Once Every 6 Months 5.6.4. Once a Year 5.6.5. Less Than Once A Year 6. Market Trends & Dynamics 6.1. Per capita spending 6.2. Key Trends Impacting the Market 6.3. Product Innovation / Development Trends 6.3.1. Latest Trends and Demands 6.3.2. Latest Innovations and New Launches 6.4. Future Prospects of the Device Industry 6.5. Market Dynamics 6.5.1. Drivers 6.5.2. Restraints 6.5.3. Opportunity Analysis 7. Value-Added Insights 7.1. Key Promotional Strategies, by Manufacturers 7.2. Key Regulations 7.3. PESTLE Analysis 7.4. Porter’s Analysis 7.5. Value Chain Analysis 8. Market Background 8.1. Macro-Economic Factors 8.1.1. Global GDP Growth Outlook 8.1.2. Global Healthcare Expenditure 8.1.3. Global Personal Care Market Overview 8.2. Forecast Factors - Relevance & Impact 8.2.1. Top Companies Historical Growth 8.2.2. New Product Launches and Approvals 8.2.3. R&D Expenditure by Key Players 8.2.4. Historic and Current Revenue of key players 8.2.5. Strategic Developments by Key Players 8.2.6. Increase Occurrence of Chronic Diseases 8.2.7. Strategic Collaborations among Players 9. Global Market Demand Analysis 2017 to 2022 and Forecast, 2023 to 2033 9.1. Historical Market Volume (Units) Analysis, 2017 to 2022 9.2. Current and Future Market Volume (Units) Projections, 2023 to 2033 9.2.1. Y-o-Y Growth Trend Analysis Per Capita Consumption 10. Global Market - Pricing Analysis 10.1. Regional Pricing Analysis By Application 10.2. Global Average Pricing Analysis Benchmark 10.3. Pricing Assumptions 11. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 11.1. Historical Market Size (US$ Million) and Volume (Units) Analysis, 2017 to 2022 11.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 11.2.1. Y-o-Y Growth Trend Analysis 11.2.2. Absolute $ Opportunity Analysis 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Application 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 12.3.1. Cold/Cough 12.3.2. Nasal Allergies 12.3.3. Nasal Congestion 12.3.4. Others 12.4. Market Attractiveness Analysis By Application 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Million) Analysis By Distribution Channel, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033 13.3.1. Retail Pharmacies 13.3.2. Hospital Pharmacies 13.3.3. E-Commerce 13.3.4. Hypermarket/Supermarket 13.4. Market Attractiveness Analysis By Distribution Channel 14. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 14.1. Introduction 14.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 14.3.1. North America 14.3.2. Latin America 14.3.3. Europe 14.3.4. South Asia 14.3.5. East Asia 14.3.6. Oceania 14.3.7. Middle East & Africa 14.4. Market Attractiveness Analysis By Region 15. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. USA 15.3.1.2. Canada 15.3.2. By Application 15.3.3. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Application 15.4.3. By Distribution Channel 15.5. Market Trends 15.6. Market Drivers & Restraints – Intensity Mapping 15.7. Country Level Analysis & Forecast 15.7.1. USA Market 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Application 15.7.1.2.2. By Distribution Channel 15.7.2. Canada Market 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Application 15.7.2.2.2. By Distribution Channel 16. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Brazil 16.3.1.2. Mexico 16.3.1.3. Argentina 16.3.1.4. Rest of LATAM 16.3.2. By Application 16.3.3. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Application 16.4.3. By Distribution Channel 16.5. Market Trends 16.6. Market Drivers & Restraints – Intensity Mapping 16.7. Country Level Analysis & Forecast 16.7.1. Brazil Market 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Application 16.7.1.2.2. By Distribution Channel 16.7.2. Mexico Market 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Application 16.7.2.2.2. By Distribution Channel 16.7.3. Argentina Market 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast by Market Taxonomy 16.7.3.2.1. By Application 16.7.3.2.2. By Distribution Channel 17. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. UK 17.3.1.2. Germany 17.3.1.3. France 17.3.1.4. Italy 17.3.1.5. Spain 17.3.1.6. BENELUX 17.3.1.7. Russia 17.3.1.8. Rest of Europe 17.3.2. By Application 17.3.3. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Application 17.4.3. By Distribution Channel 17.5. Market Trends 17.6. Market Drivers & Restraints – Intensity Mapping 17.7. Country Level Analysis & Forecast 17.7.1. UK Market 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Application 17.7.1.2.2. By Distribution Channel 17.7.2. Germany Market 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Application 17.7.2.2.2. By Distribution Channel 17.7.3. France Market 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast by Market Taxonomy 17.7.3.2.1. By Application 17.7.3.2.2. By Distribution Channel 17.7.4. Spain Market 17.7.4.1. Introduction 17.7.4.2. Market Analysis and Forecast by Market Taxonomy 17.7.4.2.1. By Application 17.7.4.2.2. By Distribution Channel 17.7.5. Italy Market 17.7.5.1. Introduction 17.7.5.2. Market Analysis and Forecast by Market Taxonomy 17.7.5.2.1. By Application 17.7.5.2.2. By Distribution Channel 17.7.6. BENELUX Market 17.7.6.1. Introduction 17.7.6.2. Market Analysis and Forecast by Market Taxonomy 17.7.6.2.1. By Application 17.7.6.2.2. By Distribution Channel 17.7.7. Russia Market 17.7.7.1. Introduction 17.7.7.2. Market Analysis and Forecast by Market Taxonomy 17.7.7.2.1. By Application 17.7.7.2.2. By Distribution Channel 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Application 18.3.3. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Application 18.4.3. By Distribution Channel 18.5. Market Trends 18.6. Market Drivers & Restraints - Intensity Mapping 18.7. Country Level Analysis & Forecast 18.7.1. China Market 18.7.1.1. Introduction 18.7.1.2. Market Analysis and Forecast by Market Taxonomy 18.7.1.2.1. By Application 18.7.1.2.2. By Distribution Channel 18.7.2. Japan Market 18.7.2.1. Introduction 18.7.2.2. Market Analysis and Forecast by Market Taxonomy 18.7.2.2.1. By Application 18.7.2.2.2. By Distribution Channel 18.7.3. South Korea Market 18.7.3.1. Introduction 18.7.3.2. Market Analysis and Forecast by Market Taxonomy 18.7.3.2.1. By Application 18.7.3.2.2. By Distribution Channel 19. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. India 19.3.1.2. Indonesia 19.3.1.3. Thailand 19.3.1.4. Malaysia 19.3.1.5. Rest of South Asia 19.3.2. By Application 19.3.3. By Distribution Channel 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Application 19.4.3. By Distribution Channel 19.5. Market Trends 19.6. Market Drivers & Restraints - Intensity Mapping 19.7. Country Level Analysis & Forecast 19.7.1. India Market 19.7.1.1. Introduction 19.7.1.2. Market Analysis and Forecast by Market Taxonomy 19.7.1.2.1. By Application 19.7.1.2.2. By Distribution Channel 19.7.2. Indonesia Market 19.7.2.1. Introduction 19.7.2.2. Market Analysis and Forecast by Market Taxonomy 19.7.2.2.1. By Application 19.7.2.2.2. By Distribution Channel 19.7.3. Thailand Market 19.7.3.1. Introduction 19.7.3.2. Market Analysis and Forecast by Market Taxonomy 19.7.3.2.1. By Application 19.7.3.2.2. By Distribution Channel 19.7.4. Malaysia Market 19.7.4.1. Introduction 19.7.4.2. Market Analysis and Forecast by Market Taxonomy 19.7.4.2.1. By Application 19.7.4.2.2. By Distribution Channel 20. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 20.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. Australia 20.3.1.2. New Zealand 20.3.2. By Application 20.3.3. By Distribution Channel 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Application 20.4.3. By Distribution Channel 20.5. Market Trends 20.6. Market Drivers & Restraints – Intensity Mapping 20.7. Country Level Analysis & Forecast 20.7.1. Australia Market 20.7.1.1. Introduction 20.7.1.2. Market Analysis and Forecast by Market Taxonomy 20.7.1.2.1. By Application 20.7.1.2.2. By Distribution Channel 20.7.2. New Zealand Market 20.7.2.1. Introduction 20.7.2.2. Market Analysis and Forecast by Market Taxonomy 20.7.2.2.1. By Application 20.7.2.2.2. By Distribution Channel 21. Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 21.1. Introduction 21.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 21.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033 21.3.1. By Country 21.3.1.1. GCC Countries 21.3.1.2. Türkiye 21.3.1.3. South Africa 21.3.1.4. North Africa 21.3.1.5. Rest of MEA 21.3.2. By Application 21.3.3. By Distribution Channel 21.4. Market Attractiveness Analysis 21.4.1. By Country 21.4.2. By Application 21.4.3. By Distribution Channel 21.5. Market Trends 21.6. Market Drivers & Restraints – Intensity Mapping 21.7. Country Level Analysis & Forecast 21.7.1. GCC Countries Market 21.7.1.1. Introduction 21.7.1.2. Market Analysis and Forecast by Market Taxonomy 21.7.1.2.1. By Application 21.7.1.2.2. By Distribution Channel 21.7.2. Türkiye Market 21.7.2.1. Introduction 21.7.2.2. Market Analysis and Forecast by Market Taxonomy 21.7.2.2.1. By Application 21.7.2.2.2. By Distribution Channel 21.7.3. South Africa Market 21.7.3.1. Introduction 21.7.3.2. Market Analysis and Forecast by Market Taxonomy 21.7.3.2.1. By Application 21.7.3.2.2. By Distribution Channel 21.7.4. North Africa Market 21.7.4.1. Introduction 21.7.4.2. Market Analysis and Forecast by Market Taxonomy 21.7.4.2.1. By Application 21.7.4.2.2. By Distribution Channel 22. Market Structure Analysis 22.1. Market Analysis by Tier of Companies 22.2. Market Share Analysis of Top Players 22.3. Market Presence Analysis 23. Competition Analysis 23.1. Competition Dashboard 23.2. Branding and Promotional Strategies, By Key Players 23.3. Key Development Analysis 23.4. Competition Deep Dive 23.4.1. Glaxosmithkline. 23.4.1.1. Overview 23.4.1.2. Product Portfolio 23.4.1.3. Key Financials 23.4.1.4. Sales Footprint 23.4.1.5. Strategy Overview 23.4.2. Abbott Laboratories 23.4.3. Procter and Gamble 23.4.4. Viatris Inc. 23.4.5. Johnson & Johnson Services, Inc. 23.4.6. Cipla Ltd. 23.4.7. INNOVUS PHARMACEUTICALS, INC 23.4.8. Novartis AG (Sandoz International GmbH) 23.4.9. Mylan N.V. 23.4.10. Sumitomo Dainippon Pharma (Sunovion Pharmaceuticals Inc.) 23.4.11. Nipro Corporation (NIPRO JMI Pharma Ltd.) 23.4.12. Glenmark pharmaceutical ltd. 23.4.13. Berry Global, Inc. 23.4.14. Astra Zeneca Plc. 23.4.15. Lupin pharmaceuticals, Inc 24. Assumptions and Acronyms Used 25. Research Methodology
Explore Healthcare Insights
View Reports
Cold Relief Roll On Market
